COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,234 Articles (22,733 medRxiv, 8,501 bioRxiv)

Most recent first Previous |  Page 1932: Articles 19311-19320  | Next

The high infectivity of SARS-CoV-2 B.1.1.7 is associated with increased interaction force between Spike-ACE2 caused by the viral N501Y mutation
Santos, J. C., Passos, G. A.
10.1101/2020.12.29.424708 — Posted: 2021-01-01
MVA Vector Vaccines Inhibit SARS CoV-2 Replication in Upper and Lower Respiratory Tracts of Transgenic Mice and Prevent Lethal Disease
Liu, R., Americo, J. L., Cotter, C. A., Earl, P. L., Erez, N., Peng, C., Moss, B.
10.1101/2020.12.30.424878 — Posted: 2021-01-01
Factors influencing intention to adhere to precautionary behavior in times of COVID- 19 pandemic in Sudan: an application of the Health Belief Model
Mehanna, A. A., Elhadi, Y. A. M., Lucero-Prisno, D. E.
10.1101/2020.12.25.20248859 — Posted: 2020-12-31
Longitudinal variability in mortality predicts Covid-19 deaths
Lundberg, J. O., Zeberg, H.
10.1101/2020.12.25.20248853 — Posted: 2020-12-30 Discussion: Onsite
Acceptable Performance of the Abbott ID NOW Among Symptomatic Individuals with Confirmed COVID-19
Stokes, W., Berenger, B., Singh, T., Adeghe, I., Schneider, A., Portnoy, D., King, T., Scott, B., Pabbaraju, K., Shokoples, S., Wong, A. A.-T., Gill, K., Turnbull, L., Hu, J., Tipples, G.
10.1101/2020.12.24.20248786 — Posted: 2020-12-30
Staff to staff transmission as a driver of healthcare worker infections with COVID-19
Gordon, C. L., Trubiano, J. A., Holmes, N. E., Chua, K. Y., Feldman, J., Young, G., Sherry, N. L., Grayson, M. L., Kwong, J. C.
10.1101/2020.12.25.20248824 — Posted: 2020-12-30
Will Proton Pump Inhibitors Lead to a Higher Risk of COVID-19 Infection and Progression to Severe Disease? A Meta-analysis
Yan, C., Chen, Y., Sun, C., Ayaz Ahmed, M., Bhan, C., Cheng, C., Hu, L., Guo, Z., Yang, H., Cao, C., Ji, Z., Yan, Y., Zuo, Y., Sun, Y., Li, Y., Zhou, Q.
10.1101/2020.12.25.20248860 — Posted: 2020-12-30
Genomic Diversity of the SARS-CoV-2 in Turkey and the Impact of Virus Genome Mutations on Clinical Outcomes
Karacan, I., Kizilboga Akgun, T., Agaoglu, N. B., Zolfagharian, P., Aydin, M., Alkurt, G., Yildiz, J., Kose, B., Can, N. D., Ozel, A. S., Altunal, N., Irvem, A., Kendir Demirkol, Y., Akgun Dogan, O., Doganay, L., Dinler Doganay, G.
10.1101/2020.12.25.20248851 — Posted: 2020-12-30
Contact Tracing of COVID-19 in Karnataka, India: Superspreading and Determinants of Infectiousness and Symptomaticity
Gupta, M., Parameswaran, G. G., Sra, M. S., Mohanta, R., Patel, D., Gupta, A., Bansal, B., Mazumder, A., Arora, M., Aggarwal, N., Bhatnagar, T., Akhtar, J., Pandey, P., Ravi, V., Babu, G. R., iCART (India COVID-19 Apex Research Team)
10.1101/2020.12.25.20248668 — Posted: 2020-12-30
The interplay between subcritical fluctuations and import: understanding COVID-19 epidemiology dynamics
Stollenwerk, N., Bidaurrazaga, J., Mar, J., Eguiguren, I., Cusimano, N., Aguiar, M.
10.1101/2020.12.25.20248840 — Posted: 2020-12-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).